China's pharmaceutical contractors show financial resilience against US supply chain curbs, with Genscript Biotech raising its full-year guidance for its life science service segment.
US District Chief Judge James Boasberg granted WuXi a preliminary injunction stopping the Department of Defence from enforcing its 1260H designation while a lawsuit proceeds.
WuXi AppTec reported a 33.7 per cent rise in H1 net profit to 11.08 billion yuan, beating expectations driven by strong demand for weight-loss and diabetes drugs and US growth.
Wuxi AppTec, Asia's largest contract pharmaceutical research provider, reported H1 net income of 11.08 billion yuan, surpassing market estimates. This strong performance was driven by robust demand for weight-loss and diabetes drugs, alongside significant growth in its US business.
WuXi AppTec's Hong Kong-traded stock jumped 37% as major shareholders JPMorgan Chase, UBS Group, and BlackRock increased their stakes. The company is set to release its half-year earnings on August 3, with high market expectations.
Shanghai-listed Piotech plans to acquire a controlling stake in Wuxi Shangji Semiconductor. The deal, funded by share issuance and cash, aims to expand Piotech's offerings beyond thin-film deposition and wafer-bonding technologies.
An unemployed man in Wuxi, China, surnamed Wan, ordered fried rice and requested extra due to financial hardship. The restaurant not only provided a larger portion but also offered him an apprenticeship, leading to widespread social media praise for the owner's kindness.
China sanciona 46 empresas americanas e suspende exportações de itens de dupla utilização para produtoras de terras raras e fabricantes de motores, em resposta a lista do Pentágono que inclui companhias chinesas ligadas a atividades militares.
China suspendeu exportações de itens de dupla utilização para empresas americanas como MP Materials e Aveox, citando práticas maliciosas dos EUA. Em resposta, sanções foram impostas a 46 outras empresas americanas, impedindo compradores chineses de adquirir seus produtos.
Wuxi's Huishan District is implementing the "Hui Ju Xin Guang" initiative to support new employment groups like delivery riders and drivers. The program includes "warm new" service stations, "friendly merchant" initiatives, and a "dual protection" mechanism for rights and welfare, aiming to enhance their sense of belonging and security.
The US Department of Defense added WuXi AppTec to its list of Chinese military companies. Analysts predict minimal impact on the company and the broader pharma sector due to cost efficiencies and ongoing collaboration.
The 2026 'Water Transport Jiangsu' Paddleboard Race (Wuxi Huishan Station) began on May 24th at Tangping Lake Wetland Park, Wuxi. Over 280 domestic and international enthusiasts competed in various categories, promoting the integration of sports and cultural tourism.
Coleman Wong Chak-lam claimed his first ATP Challenger title and was then told to emulate four-time grand slam winner Jannik Sinner by winning this week as well. The Hong Kong tennis star beat Adam Walton 7-5, 7-6 in the final of the Jiangxi Open on Sunday, and has risen to 110 in the world as a result. That makes the 21-year-old the highest-ranked player from the city ever, and puts a target on his back heading into the tournament in Wuxi, where he is seeded second and is scheduled to face...
Coleman Wong Chak-lam claimed his first ATP Challenger title and was then told to emulate four-time grand slam winner Jannik Sinner by winning this week as well. The Hong Kong tennis star beat Adam Walton 7-5, 7-6 in the final of the Jiangxi Open on Sunday, and has risen to 110 in the world as a result. That makes the 21-year-old the highest-ranked player from the city ever, and puts a target on his back heading into the tournament in Wuxi, where he is seeded second and is scheduled to face...
WuXi AppTec reported record Q1 revenue of 12.44 billion yuan (US$1.72 billion), up 28.81% year-on-year, beating market expectations of 10.78 billion yuan. Net profit rose nearly 27% to 4.65 billion yuan, exceeding forecasts of 3.9 billion yuan. The pharmaceutical contract manufacturer has a record order backlog of 59.77 billion yuan, up 23.6% from a year earlier.
